Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: Evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA)

Modern Rheumatology

Volumn 17, Issue 2, 2007, Pages 98-105

  Yamanaka, Hisashi ^a   Inoue, Eisuke ^a   Tanaka, Eiichi ^a   Nakajima, Ayako ^a   Taniguchi, Atsuo ^a   Terai, Chihiro ^a   Hara, Masako ^a   Tomatsu, Taisuke ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cohort study; Dose; Efficacy; Methotrexate; Rheumatoid arthritis

Indexed keywords

FOLIC ACID; METHOTREXATE; PREDNISOLONE; STEROID;

ADULT; ANOREXIA; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; COUGHING; DEPRESSION; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; ECZEMA; EVIDENCE BASED MEDICINE; FATIGUE; FEMALE; HAIR LOSS; HEALTH ASSESSMENT QUESTIONNAIRE; HEARTBURN; HUMAN; JAPAN; LEUKOPENIA; LIVER DYSFUNCTION; LIVER TOXICITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MOON FACE; NAUSEA; OBSERVATIONAL STUDY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SELF REPORT; SKIN PRURITUS; STOMACH PAIN; STOMATITIS; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; METHOTREXATE; PREDNISOLONE; SAFETY;

EID: 34247207578     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0546-7     Document Type: Article

References (18)

1. AL Weaver 2004 The impact of new biologicals in the treatment of rheumatoid arthritis Rheumatology (Oxf) 43 Suppl 3 iii17-iii23 10.1093/ rheumatology/keh203
2. Y Yazici T Sokka H Kautiainen C Swearingen I Kulman T Pincus 2005 Long term safety of methotrexate in routine clinical care: Discontinuation is unusual and rarely the result of laboratory abnormalities Ann Rheum Dis 64 2 207-11 15208176 10.1136/ard.2004.023408 1:CAS:528:DC%2BD2MXhvFyrtb4%3D
3. AC Cannella JR O'Dell 2003 Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis? Curr Opin Rheumatol 15 3 185-92 12707569 10.1097/00002281-200305000-00003
4. T Pincus Y Yazici T Sokka D Aletaha JS Smolen 2003 Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis Clin Exp Rheumatol 21 5 Suppl 31 S179-85 14969073 1:STN:280:DC%2BD2c%2FotVSjtw%3D%3D
5. HK Choi MA Hernan JD Seeger JM Robins F Wolfe 2002 Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study Lancet 359 9313 1173-7 11955534 10.1016/S0140-6736(02)08213-2 1:CAS:528:DC%2BD38XivVShsrw%3D
6. P Seideman 1993 Methotrexate - the relationship between dose and clinical effect Br J Rheumatol 32 8 751-3 8348281 10.1093/rheumatology/ 32.8.751 1:STN:280:ByyA2M%2FnvFY%3D
7. S Kashiwazaki Y Ichikawa S Sugawara I Nagaya S Kawai M Hakoda 1996 Determination of the clinical optimal dose of L-377 (methotrexate capsule) for the treatment of rheumatoid arthritis (in Japanese) Jpn J Inflamm 16 6 437-58
8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines 2002 Guidelines for the management of rheumatoid arthritis: 2002 update Arthritis Rheum 46 2 328-46 10.1002/art.10148
9. S Pavy A Constantin T Pham L Gossec JF Maillefert A Cantagrel 2006 Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion Joint Bone Spine 73 4 388-95 16626993 10.1016/j.jbspin.2006.01.007 1:CAS:528:DC%2BD28XptVKjtL0%3D
10. D van der Heijde L Klareskog V Rodriguez-Valverde C Codreanu H Bolosiu J Melo-Gomes 2006 Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial Arthritis Rheum 54 4 1063-74 16572441 10.1002/art.21655 1:CAS:528:DC%2BD28XksVyht7o%3D
11. YP Goekoop-Ruiterman JK de Vries-Bouwstra CF Allaart D van Zeben PJ Kerstens JM Hazes 2005 Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial Arthritis Rheum 52 11 3381-90 16258899 10.1002/art.21405 1:CAS:528:DC%2BD2MXht1KrtbfL
12. Y Matsuda G Singh H Yamanaka E Tanaka W Urano A Taniguchi 2003 Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis Arthritis Rheum 49 6 784-8 14673964 10.1002/art.11465
13. E Tanaka A Saito S Kamitsuji T Yamada A Nakajima A Taniguchi 2005 Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set Arthritis Rheum 53 6 864-71 16342105 10.1002/art.21589
14. H Yamanaka S Tohma 2006 Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice Mod Rheumatol 16 2 75-6 16633925 10.1007/s10165-006-0464-8
15. ML Prevoo IH Kuper MA van't Hof MA van Leeuwen LB van de Putte PL van Riel 1996 Validity and reproducibility of self-administered joint counts. A prospective longitudinal followup study in patients with rheumatoid arthritis J Rheumatol 23 5 841-5 8724295 1:STN:280:BymA3MrnsVY%3D
16. SL Whittle RA Hughes 2004 Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review Rheumatology (Oxf) 43 3 267-71 10.1093/rheumatology/keh088 1:CAS:528:DC%2BD2cXht1Kksbo%3D
17. P Ranganathan HL McLeod 2006 Methotrexate pharmacogenetics: The first step toward individualized therapy in rheumatoid arthritis Arthritis Rheum 54 5 1366-77 16645965 10.1002/art.21762 1:CAS:528:DC%2BD28XlsFSqurw%3D
18. H Yamanaka E Inoue E Tanaka T Yamada A Nakajima A Taniguchi 2006 Tight control of the disease activity successfully prevent the progression of disability in a large observational cohort of rheumatoid arthritis patients in Japan Arthritis Rheum 52 9 S452